Cargando…
Statistical methods for analyzing immunosignatures
BACKGROUND: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175483/ https://www.ncbi.nlm.nih.gov/pubmed/21854615 http://dx.doi.org/10.1186/1471-2105-12-349 |
_version_ | 1782212161974566912 |
---|---|
author | Brown, Justin R Stafford, Phillip Johnston, Stephen A Dinu, Valentin |
author_facet | Brown, Justin R Stafford, Phillip Johnston, Stephen A Dinu, Valentin |
author_sort | Brown, Justin R |
collection | PubMed |
description | BACKGROUND: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease status, the complex patterns and latent factors underlying immunosignatures, which we attempt to model, may have a diverse range of applications. METHODS: We investigate the utility of a number of statistical methods to determine model performance and address challenges inherent in analyzing immunosignatures. Some of these methods include exploratory and confirmatory factor analyses, classical significance testing, structural equation and mixture modeling. RESULTS: We demonstrate an ability to classify samples based on disease status and show that immunosignaturing is a very promising technology for screening and presymptomatic screening of disease. In addition, we are able to model complex patterns and latent factors underlying immunosignatures. These latent factors may serve as biomarkers for disease and may play a key role in a bioinformatic method for antibody discovery. CONCLUSION: Based on this research, we lay out an analytic framework illustrating how immunosignatures may be useful as a general method for screening and presymptomatic screening of disease as well as antibody discovery. |
format | Online Article Text |
id | pubmed-3175483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31754832011-09-21 Statistical methods for analyzing immunosignatures Brown, Justin R Stafford, Phillip Johnston, Stephen A Dinu, Valentin BMC Bioinformatics Methodology Article BACKGROUND: Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease status, the complex patterns and latent factors underlying immunosignatures, which we attempt to model, may have a diverse range of applications. METHODS: We investigate the utility of a number of statistical methods to determine model performance and address challenges inherent in analyzing immunosignatures. Some of these methods include exploratory and confirmatory factor analyses, classical significance testing, structural equation and mixture modeling. RESULTS: We demonstrate an ability to classify samples based on disease status and show that immunosignaturing is a very promising technology for screening and presymptomatic screening of disease. In addition, we are able to model complex patterns and latent factors underlying immunosignatures. These latent factors may serve as biomarkers for disease and may play a key role in a bioinformatic method for antibody discovery. CONCLUSION: Based on this research, we lay out an analytic framework illustrating how immunosignatures may be useful as a general method for screening and presymptomatic screening of disease as well as antibody discovery. BioMed Central 2011-08-19 /pmc/articles/PMC3175483/ /pubmed/21854615 http://dx.doi.org/10.1186/1471-2105-12-349 Text en Copyright ©2011 Brown et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Article Brown, Justin R Stafford, Phillip Johnston, Stephen A Dinu, Valentin Statistical methods for analyzing immunosignatures |
title | Statistical methods for analyzing immunosignatures |
title_full | Statistical methods for analyzing immunosignatures |
title_fullStr | Statistical methods for analyzing immunosignatures |
title_full_unstemmed | Statistical methods for analyzing immunosignatures |
title_short | Statistical methods for analyzing immunosignatures |
title_sort | statistical methods for analyzing immunosignatures |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175483/ https://www.ncbi.nlm.nih.gov/pubmed/21854615 http://dx.doi.org/10.1186/1471-2105-12-349 |
work_keys_str_mv | AT brownjustinr statisticalmethodsforanalyzingimmunosignatures AT staffordphillip statisticalmethodsforanalyzingimmunosignatures AT johnstonstephena statisticalmethodsforanalyzingimmunosignatures AT dinuvalentin statisticalmethodsforanalyzingimmunosignatures |